Transdermal Delivery Solutions Corp.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.tdsc.us
Dose Response Study of Transdermal Human Insulin in Patients
Phase 2
Not yet recruiting
- Conditions
- Glucose, High Blood
- Interventions
- Device: Finger-actuated, Metered Pump Sprayer
- First Posted Date
- 2021-12-16
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Transdermal Delivery Solutions Corp
- Target Recruit Count
- 30
- Registration Number
- NCT05159453
- Locations
- 🇺🇸
Langford Research Institute, Palm Beach Gardens, Florida, United States
Transdermal Insulin Response In Healthy Volunteers
Early Phase 1
Completed
- Conditions
- Pharmacodynamic Response to Small Doses of Insulin
- Interventions
- Combination Product: Human insulin
- First Posted Date
- 2021-04-23
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Transdermal Delivery Solutions Corp
- Target Recruit Count
- 7
- Registration Number
- NCT04857320
- Locations
- 🇺🇸
Langford Research Institute, Palm Beach Gardens, Florida, United States
Transdermally Delivered Human Insulin Product
Completed
- Conditions
- Hypoinsulinemia
- Interventions
- Combination Product: TD Insulin
- First Posted Date
- 2018-06-04
- Last Posted Date
- 2018-06-06
- Lead Sponsor
- Transdermal Delivery Solutions Corp
- Target Recruit Count
- 1
- Registration Number
- NCT03544996
- Locations
- 🇺🇸
Langford Research Institute, Palm Beach Gardens, Florida, United States
Product Transference Study of Testagen™ TDS®-Testosterone
Phase 2
- Conditions
- Hypogonadotropism
- Interventions
- Drug: Testagen® TDS Testosterone 5% HypoSpray®
- First Posted Date
- 2016-04-11
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Transdermal Delivery Solutions Corp
- Target Recruit Count
- 96
- Registration Number
- NCT02733133
A Dose Ranging Study to Examine TDS-Testosterone 5%
Phase 2
Not yet recruiting
- Conditions
- Hypogonadotropism
- Interventions
- Device: Pump Sprayer
- First Posted Date
- 2013-07-10
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Transdermal Delivery Solutions Corp
- Target Recruit Count
- 48
- Registration Number
- NCT01894308
- Locations
- 🇬🇧
Advanced Therapies Centre, The London Clinic, London,, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath